ROME — Doctors, nurses and the elderly rolled up their sleeves across the European Union to receive the first doses of the coronavirus vaccine Sunday in a symbolic show of unity and moment of hope for a continent confronting its worst health care crisis in a century.
Even though a few countries gave out doses a day early, the co-ordinated rollout for the 27-nation bloc was aimed at projecting a unified message that the vaccine was safe and Europe’s best chance to emerge from the pandemic and the economic devastation caused by months of lockdown.
For health care workers who have been battling the virus with only masks and shields to protect themselves, the vaccines represented an emotional relief as well as a public chance to urge Europe’s 450 million people to get the shots for their own health and that of others.
“Today I’m here as a citizen, but most of all as a nurse, to represent my category and all the health workers who choose to believe in science,” said Claudia Alivernini, 29, the first person to be inoculated at the Spallanzani infectious disease hospital in Rome.
Austrian Chancellor Sebastian Kurz called the vaccine, which was developed in record time, a “game-changer.”
“We know that today is not the end of the pandemic, but it is the beginning of the victory,” he said.
Italian virus czar Domenico Arcuri said it was significant that Italy’s first doses were administered at Spallanzani, where a Chinese couple visiting from Wuhan tested positive in January and became Italy’s first confirmed cases.
Within weeks, northern Lombardy became the epicenter of the outbreak in Europe and a cautionary tale of what happens when even wealthy regions find themselves unprepared for a pandemic. Lombardy still accounts for around a third of the dead in Italy, which has the continent’s worst confirmed virus death toll at nearly 72,000.
“Today is a beautiful, symbolic day: All the citizens of Europe together are starting to get their vaccinations, the first ray of light after a long night,” Arcuri told reporters.
But he cautioned: “We all have to continue to be prudent, cautious and responsible. We still have a long road ahead, but finally we see a bit of light.”
The vaccine developed by Germany’s BioNTech and American drugmaker Pfizer started arriving in super-cold containers at EU hospitals on Friday from a factory in Belgium. Each country was only getting a fraction of the doses needed — fewer than 10,000 in the first batches — with the bigger rollout expected in January when more vaccines become available. All those getting shots Sunday have to come back for a second dose in three weeks.
Ursula von der Leyen, head of the European Union’s Executive Commission, said with additional vaccines in development, the EU will have more shots than necessary and could share its surplus with the western Balkans and Africa.
“Europe is well positioned,” she said.
In the Los Olmos nursing home in the Spanish city of Guadalajara, northeast of Madrid, 96-year-old resident Araceli Hidalgo and a caregiver were the first Spaniards to receive the vaccine.
“Let’s see if we can all behave and make this virus go away,” Hidalgo said.
The Los Olmos home suffered two confirmed COVID-19 deaths and another 11 deaths among residents with symptoms who were never tested.
The Czech Republic was spared the worst of the pandemic in the spring only to see its health care system near collapse in the fall. In Prague, Czech Prime Minister Andrej Babis received his shot at dawn Sunday and asserted: “There’s nothing to worry about.” Sitting next to him was World War II veteran Emilie Repikova, who also received a shot.
Altogether, the EU’s 27 nations have recorded at least 16 million coronavirus infections and more than 336,000 deaths — huge numbers that experts say still understate the true toll of the pandemic due to missed cases and limited testing.
The vaccination campaign should ease frustrations that were building up, especially in Germany, as Britain, Canada and the United States kicked off their inoculation programs with the same vaccine weeks earlier.
As it turned out, some EU immunizations began a day early in Germany, Hungary and Slovakia. The operator of a German nursing home where dozens were vaccinated Saturday, including a 101-year-old woman, said “every day that we wait is one day too many.”
In France, where many question the safety of vaccines, the French government has been cautious in its messaging and keen to ensure that it is not seen as forcing vaccinations on the public. France’s first vaccination at a nursing home in a poor area outside of Paris on Sunday was not broadcast on live television as it was elsewhere in Europe and no government ministers attended.
“We didn’t need to convince her. She said ‘yes, I’m ready for anything to avoid getting this disease,’” said Dr. Samir Tine, head of geriatric services for the Sevran nursing home where France’s first shot went to 78-year-old Mauricette.
“It’s an important day,” Tine said. “We are very eager to have a new weapon at our disposal and we are very eager to rediscover our normal lives.”
Among the politicians who got shots Sunday to promote a wider acceptance of vaccinations was Bulgarian Health Minister Kostadin Angelov. “I can’t wait to see my 70-year-old father without fear that I could infect him,” Angelov said.
After he got his shot, Greek Prime Minister Kyriakos Mitsotakis declared Sunday “a great day for science and the European Union.”
“We hope that, with time, even those of our fellow citizens who are suspicious of vaccination will be convinced it is the right thing to do,” he said.
Meanwhile, a new virus variant that has been spreading rapidly around London and southern England has now been detected in France, Italy, Spain, Canada and Japan. The new variant, which British authorities said is much more easily transmitted, has prompted many countries to restrict travel from Britain.
Japan announced it would temporarily ban all non-resident foreigners from entering through Jan. 31 as a precaution against the U.K.’s new variant.
Germany’s BioNTech has said it’s confident that its vaccine works against the new U.K. variant, but added that further studies are needed.
The European Medicines Agency on Jan. 6 will consider approving another vaccine made by Moderna, which is already being used in the United States.
Dr. Annalisa Malara, who diagnosed Italy’s first domestic case on Feb. 20 that confirmed Europe’s outbreak was underway, was on hand at her hospital in Codogno to encourage all Italians to get the shot.
“Today we close the circle a bit that was opened on Feb. 20,” she said.
___
AP journalists from around Europe contributed to this report.
___
Follow AP’s coverage at https://apnews.com/hub/coronavirus-pandemic, https://apnews.com/hub/coronavirus-vaccine and https://apnews.com/UnderstandingtheOutbreak
The Canadian government says it will donate up to 200,000 vaccine doses to fight the mpox outbreak in Congo and other African countries.
It says the donated doses of Imvamune will come from Canada’s existing supply and will not affect the country’s preparedness for mpox cases in this country.
Minister of Health Mark Holland says the donation “will help to protect those in the most affected regions of Africa and will help prevent further spread of the virus.”
Dr. Madhukar Pai, Canada research chair in epidemiology and global health, says although the donation is welcome, it is a very small portion of the estimated 10 million vaccine doses needed to control the outbreak.
Vaccine donations from wealthier countries have only recently started arriving in Africa, almost a month after the World Health Organization declared the mpox outbreak a public health emergency of international concern.
A few days after the declaration in August, Global Affairs Canada announced a contribution of $1 million for mpox surveillance, diagnostic tools, research and community awareness in Africa.
On Thursday, the Africa Centres for Disease Control and Prevention said mpox is still on the rise and that testing rates are “insufficient” across the continent.
Jason Kindrachuk, Canada research chair in emerging viruses at the University of Manitoba, said donating vaccines, in addition to supporting surveillance and diagnostic tests, is “massively important.”
But Kindrachuk, who has worked on the ground in Congo during the epidemic, also said that the international response to the mpox outbreak is “better late than never (but) better never late.”
“It would have been fantastic for us globally to not be in this position by having provided doses a much, much longer time prior than when we are,” he said, noting that the outbreak of clade I mpox in Congo started in early 2023.
Clade II mpox, endemic in regions of West Africa, came to the world’s attention even earlier — in 2022 — as that strain of virus spread to other countries, including Canada.
Two doses are recommended for mpox vaccination, so the donation may only benefit 100,000 people, Pai said.
Pai questioned whether Canada is contributing enough, as the federal government hasn’t said what percentage of its mpox vaccine stockpile it is donating.
“Small donations are simply not going to help end this crisis. We need to show greater solidarity and support,” he said in an email.
“That is the biggest lesson from the COVID-19 pandemic — our collective safety is tied with that of other nations.”
This report by The Canadian Press was first published Sept. 13, 2024.
Canadian Press health coverage receives support through a partnership with the Canadian Medical Association. CP is solely responsible for this content.
HALIFAX – The Nova Scotia government says it could be months before it reveals how many people are on the wait-list for a family doctor.
The head of the province’s health authority told reporters Wednesday that the government won’t release updated data until the 160,000 people who were on the wait-list in June are contacted to verify whether they still need primary care.
Karen Oldfield said Nova Scotia Health is working on validating the primary care wait-list data before posting new numbers, and that work may take a matter of months. The most recent public wait-list figures are from June 1, when 160,234 people, or about 16 per cent of the population, were on it.
“It’s going to take time to make 160,000 calls,” Oldfield said. “We are not talking weeks, we are talking months.”
The interim CEO and president of Nova Scotia Health said people on the list are being asked where they live, whether they still need a family doctor, and to give an update on their health.
A spokesperson with the province’s Health Department says the government and its health authority are “working hard” to turn the wait-list registry into a useful tool, adding that the data will be shared once it is validated.
Nova Scotia’s NDP are calling on Premier Tim Houston to immediately release statistics on how many people are looking for a family doctor. On Tuesday, the NDP introduced a bill that would require the health minister to make the number public every month.
“It is unacceptable for the list to be more than three months out of date,” NDP Leader Claudia Chender said Tuesday.
Chender said releasing this data regularly is vital so Nova Scotians can track the government’s progress on its main 2021 campaign promise: fixing health care.
The number of people in need of a family doctor has more than doubled between the 2021 summer election campaign and June 2024. Since September 2021 about 300 doctors have been added to the provincial health system, the Health Department said.
“We’ll know if Tim Houston is keeping his 2021 election promise to fix health care when Nova Scotians are attached to primary care,” Chender said.
This report by The Canadian Press was first published Sept. 11, 2024.
ST. JOHN’S, N.L. – Newfoundland and Labrador‘s chief medical officer is monitoring the rise of whooping cough infections across the province as cases of the highly contagious disease continue to grow across Canada.
Dr. Janice Fitzgerald says that so far this year, the province has recorded 230 confirmed cases of the vaccine-preventable respiratory tract infection, also known as pertussis.
Late last month, Quebec reported more than 11,000 cases during the same time period, while Ontario counted 470 cases, well above the five-year average of 98. In Quebec, the majority of patients are between the ages of 10 and 14.
Meanwhile, New Brunswick has declared a whooping cough outbreak across the province. A total of 141 cases were reported by last month, exceeding the five-year average of 34.
The disease can lead to severe complications among vulnerable populations including infants, who are at the highest risk of suffering from complications like pneumonia and seizures. Symptoms may start with a runny nose, mild fever and cough, then progress to severe coughing accompanied by a distinctive “whooping” sound during inhalation.
“The public, especially pregnant people and those in close contact with infants, are encouraged to be aware of symptoms related to pertussis and to ensure vaccinations are up to date,” Newfoundland and Labrador’s Health Department said in a statement.
Whooping cough can be treated with antibiotics, but vaccination is the most effective way to control the spread of the disease. As a result, the province has expanded immunization efforts this school year. While booster doses are already offered in Grade 9, the vaccine is now being offered to Grade 8 students as well.
Public health officials say whooping cough is a cyclical disease that increases every two to five or six years.
Meanwhile, New Brunswick’s acting chief medical officer of health expects the current case count to get worse before tapering off.
A rise in whooping cough cases has also been reported in the United States and elsewhere. The Pan American Health Organization issued an alert in July encouraging countries to ramp up their surveillance and vaccination coverage.
This report by The Canadian Press was first published Sept. 10, 2024.
